Early trials show an average of 24% weight loss over 48 weeks higher than semaglutide or tirzepatide
However, this can only be done if your clinician advises that its safe for you to do so and is the right move for your overall health
Koye DN, Ling J, Dibato J, Khunti K, Montvida O, Paul SK (2020) Temporal trend in young-onset type 2 diabetesmacrovascular and mortality risk: study of UK primary care electronic medical records
Lyubartseva, G., Smith, J
Retatrutide is currently the most powerful weight loss peptide in clinical development, producing 24.2% average weight loss over 48 weeks in Phase 2 trials
Nausea usually comes back for a few days, though you might handle it better with experience